Kat Nestel

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Birth nameKatherine Maray Nestel
Born (1990-04-03) April 3, 1990 (age 28)
Orange County, California, United States
GenresPop, Rock
Occupation(s)Musician, songwriter
InstrumentsGuitar, Vocals
Years active2008–present
Associated actsThe Dirty Heads, The Monsters and the Strangerz, Vicetone

Katherine "Kat" Nestel (born April 3, 1990) is an American recording artist and songwriter. In June 2013 she signed with management company 1916 MGMT,[1] and soon after she signed a publishing deal with BMG Chrysalis. As of February 2014, Kat has signed with production team The Monsters and the Strangerz for her artist project. She is currently writing on various Top 40 projects with The Suspex, Jonas Jeberg, Matt Squire, The Stereotypes, Jean Baptiste and more. Kat gained mainstream recognition for her brief stint on the popular Fox show American Idol.[2] She has also gained notability from her various YouTube videos with Rome from Sublime with Rome, many of which have garnered over 2 million views. In 2010, Kat sang background vocals on the Dirty Heads song "Lay Me Down" which eventually became a #1 Hit on the Billboard Alternative and All Formats Rock charts.[3]

In January 2015, she collaborated with Dutch EDM duo Vicetone to provide vocals for the track 'No Way Out' which was released on Spinnin' Records, as well as for 'Nothing Stopping Me' and 'Angels'.


Kat is a singer/songwriter from Orange County, California. She draws inspiration from her life experiences and the artists she grew up emulating. Kat started performing at a young age, and has performed over 300 shows in Southern California since she began playing at the age of 14. Kat has formed relationships with many influential musicians and industry professionals, which has helped lead to many notable collaborations with artists like The Dirty Heads and Rome. Recently, Kat made her first national television appearance, when she performed on "Chasing Rainbows" and "Supergirl" on AXS Live.